| 1. |
Nakashima T, Matsumoto K, Yoshitake T, Wakiyama H, Hisano O, Uehara R, Takaki M, Oshima T, Yahata H, Ishigami K., Transvaginal approach combined intracavitary and interstitial brachytherapy assisted by transrectal ultrasound: results from 30 patients with locally advanced cervical cancer., Jpn J Radiol, 10.1007/s11604-023-01481-4, 2023.08. |
| 2. |
Otsuji R, Hata N, Funakoshi Y, Kuga D, Togao O, Hatae R, Sangatsuda Y, Fujioka Y, Takigawa K, Sako A, Kikuchi K, Yoshitake T, Yamamoto H, Mizoguchi M, Yoshimoto K., Supramaximal Resection Can Prolong the Survival of Patients with Cortical Glioblastoma: A Volumetric Study., Neurol Med Chir (Tokyo), 10.2176/jns-nmc.2022-0351, 2023.08. |
| 3. |
Cui Y, Arimura H, Yoshitake T, Shioyama Y, Yabuuchi H., Deep learning model fusion improves lung tumor segmentation accuracy across variable training-to-test dataset ratios., Phys Eng Sci Med., 10.1007/s13246-023-01295-8., 2023.08. |
| 4. |
Watanabe K, Kinoshita F, Takenaka T, Nagano T, Oku Y, Kosai K, Ono Y, Haratake N, Kohno M, Kamitani T, Yoshitake T, Okamoto T, Shimokawa M, Ishigami K, Yoshizumi T., Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapy., Interdiscip Cardiovasc Thorac Surg., 10.1093/icvts/ivad020., 2023.02. |
| 5. |
Funakoshi Y, Takigawa K, Hata N, Kuga D, Hatae R, Sangatsuda Y, Fujioka Y, Otsuji R, Sako A, Yoshitake T, Togao O, Hiwatashi A, Iwaki T, Mizoguchi M, Yoshimoto K. , Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective Study., World Neurosurg., 2022.03. |
| 6. |
Kodama T, Arimura H, Shirakawa Y, Ninomiya K, Yoshitake T, Shioyama Y., Relapse predictability of topological signature on pretreatment planning CT images of stage I non-small cell lung cancer patients before treatment with stereotactic ablative radiotherapy. , Thorac Cancer., 10.1371/journal.pone.0263292, 2022.01. |
| 7. |
Hirata H, Niida A, Kakiuchi N, Uchi R, Sugimachi K, Masuda T, Saito T, Kageyama SI, Motomura Y, Ito S, Yoshitake T, Tsurumaru D, Nishimuta Y, Yokoyama A, Hasegawa T, Chiba K, Shiraishi Y, Du J, Miura F, Morita M, Toh Y, Hirakawa M, Shioyama Y, Ito T, Akimoto T, Miyano S, Shibata T, Mori M, Suzuki Y, Ogawa S, Ishigami K, Mimori K. , The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy., Cancer Res, 2021.10. |
| 8. |
Funakoshi Y, Hata N, Takigawa K, Arita H, Kuga D, Hatae R, Sangatsuda Y, Fujioka Y, Sako A, Umehara T, Yoshitake T, Togao O, Hiwatashi A, Yoshimoto K, Iwaki T, Mizoguchi M., Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma., Cancer Med., 2021.05. |
| 9. |
Cui Y, Arimura H, Nakano R, Yoshitake T, Shioyama Y, Yabuuchi H., Automated approach for segmenting gross tumor volumes for lung cancer stereotactic body radiation therapy using CT-based dense V-networks. , J Radiat Res., 2021.03. |
| 10. |
Ieiri K, Shiota M, Kashiwagi E, Takeuchi A, Takahashi R, Inokuchi J, Iwai H, Shiga KI, Yokomizo A, Yoshitake T, Shioyama Y, Ishigami K, Terashima H, Eto M., The prognosis and the impact of radiotherapy in clinically regional lymph node-positive prostate cancer: Which patients are candidates for local therapy with radiation?, Urol Oncol., 2020.12. |
| 11. |
Hirose TA, Arimura H, Ninomiya K, Yoshitake T, Fukunaga JI, Shioyama Y., Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy., Sci Rep., 2020.11. |
| 12. |
Haseai S, Arimura H, Asai K, Yoshitake T, Shioyama Y. , Similar-cases-based planning approaches with beam angle optimizations using water equivalent path length for lung stereotactic body radiation therapy. , Radiol Phys Technol., 2020.06. |
| 13. |
Hata N, Mizoguchi M, Kuga D, Hatae R, Akagi Y, Sangatsuda Y, Amemiya T, Michiwaki Y, Fujioka Y, Takigawa K, Suzuki SO, Yoshitake T, Togao O, Hiwatashi A, Yoshimoto K, Iihara K., First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide., J Neurooncol., 2020.02. |
| 14. |
Hirose TA, Arimura H, Fukunaga JI, Ohga S, Yoshitake T, Shioyama Y., Observer uncertainties of soft tissue-based patient positioning in IGRT. , 2020.02. |
| 15. |
Ueda T, Koga Y, Yoshikawa H, Tanabe M, Yamana K, Oba U, Nakashima K, Ono H, Ichimura T, Hasegawa S, Kato W, Kobayashi T, Nakayama H, Sakai Y, Yoshitake T, Ohga S, Oda Y, Suzuki S, Sonoda KH, Ohga S. , Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma., BMC Pediatr., 2020.01. |
| 16. |
Nakashima T, Nonoshita T, Hirata H, Inoue K, Nagashima A, Yoshitake T, Asai K, Shioyama S., Adverse Events of Concurrent Radiotherapy and ALK Inhibitors for Brain Metastases of ALK-Rearranged Lung Adenocarcinoma., In Vivo., 2020.01. |
| 17. |
Takaki M, Ohga S, Yoshitake T, Asai K, Hirata H, Matake K, Nomoto S, Honda H, Radical Radiotherapy for Hemodialysis Patients with Esophageal Cancer, Fukuoka Acta Med., 2019.01. |
| 18. |
Inoue T, Katoh N, Ito YM, Kimura T, Nagata Y, Kuriyama K, Onishi H, Yoshitake T, Shioyama Y, Iizuka Y, Inaba K, Konishi K, Kokubo M, Karasawa K, Kozuka T, Tanaka K, Sakakibara-Konishi J, Kinoshita I, Shirato H., Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational study., Lung Cancer, 2018.08. |
| 19. |
Yoshitake T, Nakamura K, Shioyama Y, Nomoto S, Ohga S, Toba T, Shiinoki T, Anai S, Terashima H, Kishimoto J, Honda H, Breath-hold monitoring and visual feedback for radiotherapy using a charge-coupled device camera and a head-mounted display: system development and feasibility., Radiat Med, 26, 1, 50-5, 2011.07. |
| 20. |
吉武忠正, 塩山善之, 中村和正, 野元諭, 樋渡昭雄, 吉浦敬, 平田秀紀, 松本俊一, 溝口昌弘, 庄野禎久, 佐々木富男, 本田浩, 膠芽腫の放射線治療後の増悪形式とその無増悪期間、生存期間との関連について, 臨床放射線, 54, 5, 631-636, 2009.07. |
| 21. |
Yoshitake T, Shioyama Y, Nakamura K, Ohga S, Nonoshita T, Ohnishi K, Terashima K, Arimura H, Hirata H, Honda H, A clinical evaluation of visual feedback-guided breath-hold reproducibility of tumor location, Phys Med Biol, 54, 23, 7171-82, 2009.07. |
| 22. |
Yoshitake T, Nakamura K, Shioyama Y, Sasaki T, Ooga S, Abe M, Urashima Y, Urabe K, Terashima H, Honda H, Erythema multiforme and Stevens-Johnson syndrome following radiotherapy, Radiat Med, 25, 1, 27-30, 2007.07. |
| 23. |
Yoshitake T, Asayama Y, Yoshimitsu K, Irie H, Aibe H, Tajima T, Nishie A, Nakayama T, Kakihara D, Ariyoshi K, Kaneki E, Honda H, Bilateral ovarian leiomyomas: CT and MRI features, Abdom Imaging, 10.1007/s00261-004-0202-7, 30, 1, 117-119, 2005.07. |
| 24. |
Yoshitake T, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Yamaguchi T, Toba T, Anai S, Terashima H, Honda H, A machine vision system with CCD cameras for patient positioning in radiotherapy: a preliminary report, Fukuoka Igaku Zasshi, 96, 12, 399-405, 2005.07. |
| 25. |
吉武忠正, 西江昭弘, 松浦隆志, 高橋信, 吉満研吾, 入江裕之, 相部仁, 田嶋強, 篠崎賢治, 中山智博, 柿原大輔, 本田浩, Fitz-Hugh-Curtis syndrome: CT所見の検討, 日本医学放射線学会誌, 63, 6, 303-307, 2003.07. |
